Enveric Biosciences (ENVB) FCF Margin (QoQ) (2015 - 2020)
Enveric Biosciences (ENVB) FCF Margin (QoQ) (2015 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Enveric Biosciences | 5.66 Mn | -2.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -50.00 |
| Jun 30, 2020 | 555.00 |
| Mar 31, 2020 | -1,825.00 |
| Jun 30, 2019 | 473.00 |
| Mar 31, 2019 | 26.00 |
| Dec 31, 2018 | 253.00 |
| Sep 30, 2018 | -1,361.00 |
| Jun 30, 2018 | 566.00 |
| Mar 31, 2018 | 404.00 |
| Dec 31, 2017 | -740.00 |
| Sep 30, 2017 | 623.00 |
| Jun 30, 2017 | -14.00 |
| Mar 31, 2017 | 1,732.00 |
| Dec 31, 2016 | -2,977.00 |
| Sep 30, 2016 | 1,033.00 |
| Jun 30, 2016 | -506.00 |
| Mar 31, 2016 | -522.00 |
| Dec 31, 2015 | 7,831.00 |
| Sep 30, 2015 | -5,136.00 |
| Jun 30, 2015 | -1,370.00 |